tebufenozide: Clinical Trials

4 trials of tebufenozide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 not yet recruiting. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 3, Not yet recruiting 1
Phase 21Recruiting 1

Follow tebufenozide: new trials by email Literature Review of tebufenozide trials Research Report on tebufenozide

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase III Clinical Trial of Changji'an Capsules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver-Qi Invading Spleen Syndrome)
Chang Ji'an capsule, Chang Ji'an capsule mimic - IBS, Diarrhea Predominant
Phase 3Not yet recruitingBeijing Hospital of Traditional Chinese Medicine6362026-05-312026-05-28
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma
Xinlikang capsules, mimic capsules - Diffuse Large B-Cell Lymphoma (DLBCL)
Phase 2 / Phase 3RecruitingSun Yat-sen University802025-09-112025-11-26
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Buagafuran capsules, 15mg/ capsule, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder
Phase 3RecruitingBeijing Union Pharmaceutical Factory Ltd5042023-07-252024-02-06
Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Buagafuran capsules, 15mg/ capsule, Buspirone tablets, 5mg/ tablet, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder
Phase 3RecruitingBeijing Union Pharmaceutical Factory Ltd4102023-07-242024-02-06

Conditions studied

Generalized Anxiety Disorder (2)  ·  Ichthyosis Bullosa of Siemens (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)

Sponsors

Beijing Union Pharmaceutical Factory Ltd (2)  ·  Beijing Hospital of Traditional Chinese Medicine (1)  ·  Sun Yat-sen University (1)

Countries

China (4)